Ondansetron Hydrochloride
Product Images NDC 55648-727

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 55648-727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Ondansetron Sturcture)

FDA Label Image

Vial Carton 2 mL (Ondansetron Vial Carton 2 mL)

Vial Carton 2 mL (Ondansetron Vial Carton 2 mL)
This is a package insert for Ondansetron injection USP, which is a medication used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. It is a 2 mg/mL aqueous solution containing ondansetron hydrochloride dihydrate, sodium chloride, citric acid monohydrate, and sodium citrate dihydrate as buffers. The medication is manufactured by Wockhardt Limited and comes in a pack of five 2 mL single-dose vials. The insert provides dosage and administration instructions, storage instructions, and notes that the medication should be protected from light and retained in the carton until the time of use.*
FDA Label Image

Vial Carton 20 mL (Ondansetron Vial Carton 20 mL)

Vial Carton 20 mL (Ondansetron Vial Carton 20 mL)
This is a description of Ondansetron injection USP, a medication that comes in a 20 mL multidose vial, which contains 40 mg in 20 mL of 2 mg/mL strength. It is indicated for LV. or LM injection, and it comes with instructions to check the package insert for dosage and administration. Manufactured by Wockhardt Limited, Mumbai, India and distributed by Wockhardt USA LLC, this medication must be stored within a temperature range of 20°C-25°C (68°F -77°F) and protected from light. Its chemical composition consists of ondansetron hydrochloride dihydrate, sodium chloride, citric acid monohydrate, and sodium citrate dihydrate as buffers, and methylparaben and propylparaben as preservatives.*
FDA Label Image

Vial Label 2 mL (Ondansetron Vial Labels 2 mL)

Vial Label 2 mL (Ondansetron Vial Labels 2 mL)
This appears to be a label from a medication, specifically for Ondansetron injection with a concentration of 2mg/mL. The label instructs to store the medication at a temperature range of 20°-25°C (68°-77°F) and provides a National Drug Code (NDC) for the medication. The rest of the text is not legible or appears to be gibberish.*
FDA Label Image

Vial Label 20 mL (Ondansetron Vial Labels 20 mL)

Vial Label 20 mL (Ondansetron Vial Labels 20 mL)
This is a medication description. The medication contains sodium chloride 0.25g, citric acid monohydrate 8.3mg and sodium citrate dihydrate, 0.5 mg. It also contains buffers and preservatives such as methylparaben and propylparaben. Dosage and administration information can be found in the package insert. The medication should be stored at room temperature, and after opening, it should be used within a certain time frame. The medication is manufactured by Wockhardt Limited in Mumbai and distributed by Wockhardt USA in NJ. Lot number 210214, with dimensions of 7mm by 30mm, is mentioned, along with an expiry date that is not specified.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.